What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His primary scientific interests are in Amyotrophic lateral sclerosis, Internal medicine, Physical therapy, Endocrinology and Isometric exercise.
His Amyotrophic lateral sclerosis study deals with the bigger picture of Disease.
His research integrates issues of Gastroenterology and Multiple sclerosis in his study of Internal medicine.
His Physical therapy research is multidisciplinary, incorporating elements of Quality of life, Carpal tunnel syndrome, Palliative care, Neurology and Weakness.
His study in the field of Skeletal muscle, Myocyte and Dystrophin also crosses realms of Phosphocreatine.
The study incorporates disciplines such as Physical exercise and Cardiology in addition to Isometric exercise.
His most cited work include:
- El Escorial revisited : revised criteria for the diagnosis of amyotrophic lateral sclerosis (3422 citations)
- Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) (866 citations)
- Distal symmetric polyneuropathy: A definition for clinical research Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation (523 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Amyotrophic lateral sclerosis, Internal medicine, Physical therapy, Clinical trial and Disease.
The concepts of his Amyotrophic lateral sclerosis study are interwoven with issues in Placebo, Neurology, Physical medicine and rehabilitation and Intensive care medicine.
His study in Placebo is interdisciplinary in nature, drawing from both Anesthesia, Randomized controlled trial, Surgery and Adverse effect.
Robert G. Miller works mostly in the field of Internal medicine, limiting it down to topics relating to Endocrinology and, in certain cases, Multiple sclerosis.
Robert G. Miller interconnects Quality of life, Palliative care and Weakness in the investigation of issues within Physical therapy.
His studies deal with areas such as Research design, Clinical research, MEDLINE and Riluzole as well as Clinical trial.
He most often published in these fields:
- Amyotrophic lateral sclerosis (44.26%)
- Internal medicine (31.76%)
- Physical therapy (19.59%)
What were the highlights of his more recent work (between 2011-2020)?
- Amyotrophic lateral sclerosis (44.26%)
- Internal medicine (31.76%)
- Physical therapy (19.59%)
In recent papers he was focusing on the following fields of study:
Robert G. Miller focuses on Amyotrophic lateral sclerosis, Internal medicine, Physical therapy, Clinical trial and Disease.
His Amyotrophic lateral sclerosis research is included under the broader classification of Pathology.
His studies in Internal medicine integrate themes in fields like Placebo, Surgery and Oncology.
His work on Isometric exercise and Manual Muscle Testing as part of general Physical therapy study is frequently linked to Holy Grail, therefore connecting diverse disciplines of science.
His work on Clinical endpoint as part of his general Clinical trial study is frequently connected to Patient oriented, thereby bridging the divide between different branches of science.
His study on Disease also encompasses disciplines like
- C9orf72, Oxidative stress and Epidemiology most often made with reference to Family history,
- Immune system that intertwine with fields like Alzheimer's disease, Pathogenesis, Tolerability and Therapeutic approach.
Between 2011 and 2020, his most popular works were:
- Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) (866 citations)
- Controversies and priorities in amyotrophic lateral sclerosis (356 citations)
- Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. (115 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Robert G. Miller mostly deals with Amyotrophic lateral sclerosis, Internal medicine, Clinical trial, Neurology and Physical therapy.
His Amyotrophic lateral sclerosis study is concerned with the larger field of Disease.
His work deals with themes such as Placebo and Oncology, which intersect with Internal medicine.
His research in the fields of Clinical endpoint and Phases of clinical research overlaps with other disciplines such as Dexpramipexole.
His Neurology study incorporates themes from Delphi method, Outcome assessment, MEDLINE, Research design and Intensive care medicine.
When carried out as part of a general Physical therapy research project, his work on Occupational therapy is frequently linked to work in Quality measurement, therefore connecting diverse disciplines of study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
